The c-Myc/miR-22-3p/PHF8 regulatory axis acts as a biological mechanism for the dysregulation of PHF8 expression in breast cancer and gastric cancer and plays an essential role in tumor progression [43, 44]. Here, MYC is linked to breast cancer.